| Sign In to gain access to subscriptions and/or personal tools. |
The Society for Clinical Trials supports United States legislation mandating trials registrationDepartment of Community Health, Brown University, Providence, RI, USA; Center for Clinical Trials and Evidence-based Healthcare, Brown Medical School, 169 Angell Street Box G-S2, Providence, RI 02912, USA; kay_dickersin{at}brown.edu
The University of Texas School of Public Health at Houston, Houston, TX, USA,
Biostatistics Research Branch, NIH, NIAID, Bethesda, MD, USA
Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA
The Wilmer Opthalmological Institute, The Johns Hopkins University, Baltimore, MD, USA
Cooperative Studies Program Coordinating Center, Veterans, Affairs Connecticut Healthcare System
The George Washington University, Washington, DC, USA
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK The official position of the Society for Clinical Trials is to support legislation in the United States and internationally that mandates registration of all controlled clinicals trials at or before enrollment of the first participant. The major trial sponsor would be responsible for ensuring contribution of trial information. The mechanism for registering trials would be through research ethics review boards, and registration would be required for ethics approval and before trial initiation. Standardized data and a unique identification number would be available for each registered trial.
Clinical Trials, Vol. 1, No. 5,
417-420 (2004) This article has been cited by other articles:
|
|||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
